Guardant Health launches GuardantINFINITY test to advance cancer research
The test offers new genomic and epigenomic insights into tumour, tumour microenvironment, and patient immunological responses from a…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Sep 22
The test offers new genomic and epigenomic insights into tumour, tumour microenvironment, and patient immunological responses from a…
12 Sep 22
The VENTANA PD-L1 (SP263) Assay assists in selecting non-small cell lung cancer patients who can be suitable for…
12 Sep 22
A total of 6,662 people, aged 50 years or more, were involved in the single-arm study, the results…
12 Sep 22
Poster presentation at the 2022 Annual Meeting of the European Society of Medical Oncology (ESMO), Paris, France
09 Sep 22
The Full-Field Bone Marrow Aspirate Application provides an enhanced haematology workflow by utilising AI and imaging of vast…
09 Sep 22
The FDA-cleared ultrasound system is based on Crystal Architecture to provide improved image clarity and penetration
09 Sep 22
NeoDynamics is a Swedish Medical Technology Company dedicated to advancing the diagnosis and care of breast cancer
08 Sep 22
Falcon II reduces manual handling by up to 70%, replacing it with standardised automated operations, and brings down…
08 Sep 22
The Quest Monkeypox PCR is the first lab-developed test to receive the FDA emergency use authorisation for detecting…
07 Sep 22
Illumina announced that it is reviewing the EC's order on blocking the deal, while revealing its intention to…